CFI-400945

SKU: C-1105-5mg

Quantity (mg):

5 mg

Product Options

Quantity

$89.99

Catalog#: C-1105

Targets: PLK4

Synonym: CFI-400945

Chemical Name/IUPAC:1R,2S)-2-[3-[(1E)-2-[4-[[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5'-methoxy-Spiro[cyclopropane-1,3'-[3H]indol]-2'(1'H)-one

SMILES Code: O=C(NC1=C2C=C(C=C1)OC)[C@@]32[C@@H](C3)C4=CC5=C(C(/C=C/C6=CC=C(C=C6)CN7C[C@@H](O[C@@H](C7)C)C)=NN5)C=C4.O=C(O)/C=C/C(O)=O

Technical Data

Product Name: CFI-400945

Chemical Formula: C33H34N4O3

Molecular Weight: 534.64

CAS#: 1338806-73-7

Appearance: Solid powder

Purity: > 99% by HPLC

Solubility: Soluble in DMSO

Storage: Room temperature for months, or -20ºC for 3 years

Description
CFI-400945 is an orally available PLK4 (polo-like kinase 4) inhibitor with potential antineoplastic activity. Upon oral administration, CFI-400945 selectively inhibits PLK4, which results in the disruption of mitosis and the induction of apoptosis. PLK4 inhibition also prevents cell division and inhibits proliferation of PLK4-overexpressing tumor cells. PLK4, a member of the polo family of serine/threonine kinases overexpressed in a variety of cancer cell types, plays a crucial role in the regulation of centriole duplication during the cell cycle.

CFI-400945

Related products

ABT-263 (Navitoclax)

MEK-162 (ARRY-162)

E-7090

E-7080 (Lenvatinib Mesylate)